Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Annals of Clinical Microbiology and Antimicrobials|June 19, 2016
In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolatesChristina A Sutherland, Jamie E Verastegui, David P Nicolau
Infectious Diseases and Therapy|October 21, 2015
Defining Extended Spectrum β-Lactamases: Implications of Minimum Inhibitory Concentration-Based Screening Versus Clavulanate Confirmation TestingChristina A Sutherland, Jared L Crandon, David P Nicolau
Diagnostic Microbiology and Infectious Disease|June 20, 2019
In vitro investigation of synergy among fosfomycin and parenteral antimicrobials against carbapenemase-producing EnterobacteriaceaeLindsay M Avery, Christina A Sutherland, David P Nicolau
Infectious Diseases (London, England)|October 10, 2019
Single β-lactams versus combinations as empiric therapy for infections with Pseudomonas aeruginosa: assessing the in vitro susceptibilitySafa S Almarzoky Abuhussain, Christina A Sutherland, David P Nicolau
Journal of Thoracic Disease|July 10, 2019
In vitro potency of antipseudomonal β-lactams against blood and respiratory isolates of P. aeruginosa collected from US hospitalsSafa S Almarzoky Abuhussain, Christina A Sutherland, David P Nicolau
Pharmacotherapy|October 30, 2007
Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion?Aryun Kim, Christina A Sutherland, Joseph L Kuti, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 4, 2004
Quantitation of tigecycline, a novel glycylcycline [corrected] by liquid chromatographyChonghua Li, Christina A Sutherland, Charles H Nightingale, et al.
Paediatric Drugs|April 5, 2007
Pharmacokinetics of cefprozil in plasma and middle ear fluid: in children undergoing treatment for acute otitis mediaDavid P Nicolau, Christina A Sutherland, Adriano Arguedas, et al.
Pharmacotherapy|August 19, 2003
Pharmacokinetics of meropenem 0.5 and 2 g every 8 hours as a 3-hour infusionPrachi K Dandekar, Dana Maglio, Christina A Sutherland, et al.
Pageof 3